$IMLFF InMed has made significant progress in developing therapies with certain cannabinoids of the 90+ found in the cannabis plant -- not just THC and CBD -- and has a low-cost process for biosynthesizing these cannabinoids using a method that is similar to the manufacturing process for insulin. This unique approach has drawn the attention of investors, media, and high-profile industry experts.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.